Cardiol Therapeutics Inc

Here is the public summary page for Cardiol Therapeutics Inc. Please login to see the complete information for Cardiol Therapeutics Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Cardiol Therapeutics Inc stacks up relative to its peers.

Darwin Score	+13
Ticker	CRDL
Latest Price	1.91 CAD as of close on 01-Aug-2025
3 Month price range	1.24 to 2.07 CAD
Market Capitalisation	171.08Mn CAD
Country	Canada
Region	North America
Economic Sector	Health Care
Business Sector	Pharmaceuticals, Biotechnology & Life Sciences
Industry	Pharmaceuticals
Sub-Industry	Pharmaceuticals
Description	Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada. See More ...
Company URL	https://www.cardiolrx.com

See Darwins Full Analysis for Cardiol Therapeutics Inc

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Cardiol Therapeutics Inc. Further information and full detail is available when you login.

TMA Part	Focus of Analysis	TMA Score
Price	Analysis of performance, trend, RSI, OBV and moving averages	+21
Sentiment	News and Candle Patterns.	0
Fundamentals	Analyst Ratings, Valuation and Dividend analysis.	0
Flow	Institutional, Fund and Insider buying and selling.	0
Models	Forecast models.	-8